C4 Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $25k | 16k | 1.60 |
| 2024-12-31 | $104k | 29k | 3.60 |
| 2024-09-30 | $202k | 36k | 5.70 |
| 2024-06-30 | $72k | 16k | 4.62 |
| 2023-03-31 | $86k | 28k | 3.14 |
| 2022-12-31 | $162k | 28k | 5.90 |
| 2022-09-30 | $241k | 28k | 8.77 |
| 2022-06-30 | $159k | 21k | 7.54 |
| 2022-03-31 | $512k | 21k | 24.26 |
| 2021-12-31 | $429k | 13k | 32.21 |
| 2021-09-30 | $595k | 13k | 44.68 |
| 2021-06-30 | $504k | 13k | 37.84 |
| 2021-03-31 | $198k | 5.3k | 36.99 |
| 2020-12-31 | $177k | 5.3k | 33.13 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors